The role of tuberculosis in COPD

International Journal of COPD

Volumn 12, Issue , 2017, Pages 323-329

  Yakar, Halil Ibrahim ^a   Gunen, Hakan ^b   Pehlivan, Erkan ^c   Aydogan, Selma ^b  

^a ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^b Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital   (Turkey)

^c INONU UNIVERSITY   (Turkey)

Author keywords

COPD; Mortality; Tuberculosis

Indexed keywords

AGED; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BODY MASS; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEMATOCRIT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY RATE; SURVIVAL RATE; SURVIVAL TIME; TUBERCULOSIS; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMORBIDITY; DIAGNOSTIC IMAGING; DISEASE COURSE; HOSPITAL MORTALITY; HOSPITAL READMISSION; KAPLAN MEIER METHOD; LUNG; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; TIME FACTOR; TUBERCULOSIS, PULMONARY; TURKEY; VERY ELDERLY; VITAL CAPACITY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG; MALE; MIDDLE AGED; PATIENT READMISSION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TIME FACTORS; TUBERCULOSIS, PULMONARY; TURKEY; VITAL CAPACITY;

EID: 85010297266     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S116086     Document Type: Article

References (20)

1. Menezes AM, Hallal PC, Perez-Padilla R, et al; Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) Team. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J. 2007;30(6):1180–1185.
2. Hnizdo E, Singh T, Churchyard GJ. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55(1):32–38.
3. Caballero A, Torres-Duque C, Jaramillo C, et al. Prevalence of COPD in five Colombian cities situated at low, medium and high altitude (PREPOCOL Study). Chest. 2008;133(2):343–349.
4. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
5. Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculosis destroyed lung. Respir Med. 2003;97(11):1237–1242.
6. Chakrabarti B, Calverley PM, Davies PD. Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007;2(3):263–272.
7. Lam KB, Jiang CQ, Jordan RE, et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest. 2010;137(3):593–600.
8. Rhee CK, Yoo KH, Lee JH, et al. Clinical characteristics of patients with tuberculosis-destroyed lung. Int J Tuberc Lung Dis. 2013;17(1):67–75.
9. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Molken MR. Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2010;5: 435–444.
10. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest. 2007;131(3):696–704.
11. Patil SP, Krishnan JA, Lechtzin N, et al. In-hospital mortality following acute exacerbations of COPD. Arch Intern Med. 2003;163(10):1180–1186.
12. Ai-Ping C, Lee KH, Lim TK. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest. 2005;128(2):518–524.
13. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalized patients with COPD. Eur Respir J. 2005;26(2):234–241.
14. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med. 1996;154(4 pt 1):959–967.
15. Almagro P, Calbo E, Ochoa de Echaguen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121(5):1441–1448.
16. Kim S, Lee J, Park Y, et al. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis. J Korean Med Sci. 2015;30(6):737–742.
17. Aso H, Kondoh Y, Taniguchi H, et al. Noninvasive ventilation in patients with acute exacerbation of pulmonary tuberculosis sequel. Intern Med. 2010;49(19):2077–2083.
18. Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10(2):81–89.
19. Tantucci C, Donati P, Nicosia F, et al. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respir Med. 2008;102(4):613–619.
20. Schols AMW, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 pt 1):1791–1797.